by 39.71% comparing to THB 427.91 million of the same period last year (“QoQ”). Revenue from steel tower manufacturing decreased by 52.25% QoQ as a result of decreasing in number of unit deliverables
tons or 11% compared to FY2018 due to the incremental capacity of methyl ester from methyl ester plant 2 which has commenced the commercial operation in 2Q2019. In addition, at the same time, the company
to the same period of the previous year. Gross Profit and Gross Profit Margin EMS business The Company had gross profit from EMS business for 2019 amounting to Baht 264 million, which was decreased by
display, cost of sample products, expense on advertisement media such as TV media, online media, etc. At the same time, salary, bonus, welfare and commission fee for sales staff increased by about Baht 4.74
Pharma Co. Ltd. 140/9 ITF Tower, 9th Floor, Silom Road, Suriyawong, Bangrak, Bangkok 10500, Thailand. Tel. 02-634-0225 Fax 02-634-0135 www.interpharma.co.th media, online media, etc. At the same time
23.19 48.14 Cash Flow from Operating Activities CFO as of December 31, 2019 was 200.06mb, closing at the same amount last year. The management will consider using the surplus CFO in investment or any
same proportion in the investment value of secure loan and unsecure loan. The Company selection to purchase non-performing loans mainly considered the return on investment to create profits to
expenses but there is some fix cost that we can’t decrease, the ratio of selling and admin expense is almost the same with last year. • We have to record special transaction in consolidated statement for
Q1-2016, which is equal to 22.7%. Selling and Administrative Expenses Administrative expenses for Q1-2017 were approximately the same as Q1'2012, but increased from Q4-2016 at a much higher rate than